UBS raises HCA Healthcare stock price target to $635 on AI potential

robot
Abstract generation in progress

UBS has increased its price target for HCA Healthcare Inc (NYSE:HCA) shares to $635 from $598, maintaining a Buy rating, due to the potential of artificial intelligence to drive efficiency and re-rate the stock. The firm believes AI could help HCA Healthcare break through its historical 10x EBITDA valuation multiple ceiling. This comes as HCA Healthcare recently reported strong fourth-quarter 2025 earnings and management aggressively repurchased shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin